These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29132200)

  • 1. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
    Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH
    Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes.
    Vasilatou D; Papageorgiou SG; Kontsioti F; Kontos CK; Tsiotra P; Mpakou V; Pavlou MA; Economopoulou C; Dimitriadis G; Dervenoulas J; Pappa V
    Leuk Res; 2013 Mar; 37(3):251-8. PubMed ID: 23246221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
    Choi JS; Nam MH; Yoon SY; Kang SH
    Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
    Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
    Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome.
    Zuo Z; Calin GA; de Paula HM; Medeiros LJ; Fernandez MH; Shimizu M; Garcia-Manero G; Bueso-Ramos CE
    Blood; 2011 Jul; 118(2):413-5. PubMed ID: 21602527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis of differentially expressed microRNAs in myelodysplastic syndromes.
    Wan C; Wen J; Huang Y; Li H; Wu W; Xie Q; Liang X; Tang Z; Zhao W; Cheng P; Liu Z
    Medicine (Baltimore); 2020 Jul; 99(27):e20904. PubMed ID: 32629683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abnormal expression of microRNA-124 in patients with leukemia or myelodysplastic syndrome and its significance].
    Xia Q; Hu J; Meng YS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):358-61. PubMed ID: 22541098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflamma-miRs Profile in Myelodysplastic Syndrome Patients.
    Montes P; Rusanova I; Cornejo E; García P; Guerra-Librero A; López MDS; Haro T; Escames G; Acuña-Castroviejo D
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes].
    Huang Y; Wen J; Li HY; Zhang XP; Deng DH; Cheng P; Peng ZG; Zhao WH; Luo J; Long Y; Liu ZF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1476-1483. PubMed ID: 27784378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-597 in myelodysplastic syndromes induces apoptosis through FOSL2 inhibition.
    Kang SH; Kim HB; Choi JS
    Eur J Haematol; 2022 Dec; 109(6):680-685. PubMed ID: 36018564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes.
    Wan C; Wen J; Liang X; Xie Q; Wu W; Wu M; Liu Z
    Sci Rep; 2021 Jan; 11(1):183. PubMed ID: 33420276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS].
    LE Y; Zhang XP; Xiong YQ; Li HY; Zhao WH; Long Y; Luo J; Cheng P; Liu ZF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):134-140. PubMed ID: 30738460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression significance and potential mechanism of hypoxia-inducible factor 1 alpha in patients with myelodysplastic syndromes.
    Liang HW; Luo B; Du LH; He RQ; Chen G; Peng ZG; Ma J
    Cancer Med; 2019 Oct; 8(13):6021-6035. PubMed ID: 31411003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
    Hrustincova A; Krejcik Z; Kundrat D; Szikszai K; Belickova M; Pecherkova P; Klema J; Vesela J; Hruba M; Cermak J; Hrdinova T; Krijt M; Valka J; Jonasova A; Merkerova MD
    Cells; 2020 Mar; 9(4):. PubMed ID: 32224889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic microRNAs in myelodysplastic syndrome.
    Erdogan B; Facey C; Qualtieri J; Tedesco J; Rinker E; Isett RB; Tobias J; Baldwin DA; Thompson JE; Carroll M; Kim AS
    Exp Hematol; 2011 Sep; 39(9):915-926.e2. PubMed ID: 21703983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):672-7. PubMed ID: 20450725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reactivated Expression of MicroRNA-124 in Patients with Myelodysplastic Syndromes after Demethylating Therapy].
    Meng YS; Gao S; Hua FL; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1807-1810. PubMed ID: 28024498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
    Wang H; Sun J; Zhang B; Zhao D; Tong H; Wu H; Li X; Luo Y; Dong D; Yao Y; McDonald T; Stein AS; Al Malki MM; Pichiorri F; Carlesso N; Kuo YH; Marcucci G; Li L; Jin J
    Clin Transl Med; 2021 Oct; 11(10):e610. PubMed ID: 34709739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of miR-223 on cellular behaviour in non-5q myelodysplastic syndromes through targeting RPS14.
    Nie Y; Wang S; Yu Y; Zuo X; Xiong B
    Pathology; 2020 Aug; 52(5):552-560. PubMed ID: 32571542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.